Renew Labs Receives Accreditation from College of American Pathologists
Renew Labs, the clinical laboratory division of Renew Biotechnologies, has been awarded accreditation by the College of American Pathologists (CAP). The accreditation confirms the laboratory's existing quality and operational standards.
Pleasant Grove, Utah – Renew Labs, the clinical laboratory division of Renew Biotechnologies, has received accreditation from the College of American Pathologists (CAP) following a recent on-site inspection. CAP accreditation is widely recognized as a mark of laboratory quality and operational excellence.
The accreditation program is designed to help laboratories maintain rigorous standards across testing operations, quality systems, personnel qualifications, equipment, facilities, safety, and overall laboratory management. For Renew Labs, this accreditation reflects the company's commitment to establishing advanced laboratory capabilities built on clinical quality, reproducibility, and regulatory readiness.
"CAP accreditation reflects the strength of our laboratory systems and the discipline our team brings to every part of the testing process," said Ki Aston, Laboratory Director at Renew Labs. "As we continue expanding our sequencing and molecular profiling capabilities, maintaining rigorous quality standards will be central to how we support patients, providers, and partners."
Renew Biotechnologies offers a broad range of sequencing, molecular testing, assay development, and clinical laboratory programs. The company specializes in long-read and native-read sequencing, including methylation analysis, RNA characterization, and complex genomic regions. The CAP accreditation further strengthens Renew's ability to support partners in research, clinical product development, and patient-facing laboratory testing.